Serum Institute of India's Covovax has been granted Emergency Use Authorisation by DCGI for adults & for children above the age of 12. Younger age groups will follow shortly. Novavax in global trials has demonstrated more than 90% efficacy: SII CEO Adar Poonawala pic.twitter.com/TU0ggaWRfK— ANI (@ANI) March 9, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


